The Board of Directors of the Company at its meeting held on January 16, 2026 at registered office of the company, have inter-alia transacted/approved the Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter and Nine Month Ended December 31, 2025 pursuant to the Provisions of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
INDOBORAX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Borax & Chemicals has informed the exchanges that its Board of Directors met on January 16, 2026 and approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2025. The filing has been made under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements, which is a standard regulatory requirement after quarterly results are approved. No specific financial numbers, revenue figures, profit numbers, or operational details have been shared in this intimation — those will be in the actual results document. The announcement is purely procedural, confirming the board has cleared the results for submission to the exchanges.
This is a routine compliance filing with no material new information for investors. Shareholders should wait for the actual financial results document to assess revenue growth, profitability, and margin trends before making any decisions. There is no expected immediate impact on the stock price from this announcement alone.